Terminated PHASE4 INTERVENTIONAL 1-arm NCT02966002

Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients

Sponsor: University of Michigan

Interventions Aspirin

Updated 7 times since 2017 Last updated: May 17, 2018 Started: Apr 30, 2016 Primary completion: May 25, 2017 Completion: May 25, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This study was terminated due to inability to recruit sufficient patients.

Other terminated trials from University of Michigan

See all terminations from University of Michigan

A PHASE4 clinical study on Fontan Procedure, this trial is terminated or withdrawn. The trial is conducted by University of Michigan and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Dec 2017 — Jun 2018 [monthly]

Terminated PHASE4

Status: Recruiting → Terminated

▶ Show 2 earlier versions

Feb 2017 — Dec 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Michigan

Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ann Arbor, United States